Jahan Khanna

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
We show that the need to “posture” can help solve the hold-up problem inherent in many multi-stage relationships, such as those between entrepreneurs and venture capitalists (VCs). Posturing arises when an informed party needs to send a strong signal to induce skeptical third parties like employees, suppliers, customers or competitors, to develop(More)
Azelnidipine (CS-905) is a long-acting, once-daily, orally-administered calcium channel antagonist which is being jointly developed by Sankyo and UBE. An NDA for the treatment of hypertension was filed in Japan in July 1997 [314648,271372,312610]. In a clinical trial presented at the European Meeting on Hypertension in 1995, azelnidipine decreased systolic(More)
  • 1